Page last updated: 2024-09-03

etomoxir and Uterine Cervical Neoplasms

etomoxir has been researched along with Uterine Cervical Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ba, G; Chu, BB; Du, QJ; Han, J; Han, YQ; Li, J; Lu, WF; Ming, SL; Sun, MM; Wang, J; Wu, HT; Yang, GY; Zeng, L1

Other Studies

1 other study(ies) available for etomoxir and Uterine Cervical Neoplasms

ArticleYear
Myostatin knockout induces apoptosis in human cervical cancer cells via elevated reactive oxygen species generation.
    Redox biology, 2018, Volume: 19

    Topics: A549 Cells; Animals; Antioxidants; Apoptosis; Cachexia; Caspases; Cell Line, Tumor; Cell Proliferation; Clustered Regularly Interspaced Short Palindromic Repeats; CRISPR-Cas Systems; Cytochromes c; Epoxy Compounds; Fatty Acids; Female; Gene Knockout Techniques; HEK293 Cells; HeLa Cells; Humans; Lipid Metabolism; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Myostatin; Oxidation-Reduction; Reactive Oxygen Species; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays

2018